Abstract Purpose of Review Atrial fibrillation (AF) is the most common sustained cardiac
arrhythmia. The estimated lifetime risk of developing AF is higher in men; however, due to …

Aims To assess the impact of anticoagulant treatment on risk for stroke and all-cause
mortality of patients with atrial fibrillation using real-world data (RWD). Methods Patients with …

Background The choice to recommend antithrombotic therapy to patients with atrial
fibrillation should rely on cardioembolic and bleeding risk stratification. Sharing some risk …

Background Non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) are widely used
as stroke prophylaxis in non-valvular atrial fibrillation (AF), but comparative data are sparse …

Despite relatively lower prevalence of atrial fibrillation (AF) in Asians (~ 1%) than in
Caucasians (~ 2%), Asia has a much higher overall disease burden because of its …

Background and Purpose—The main objective of the present analysis was to assess the
effect of treatment with aspirin compared with apixaban on ischemic stroke and major …

Background Women with atrial fibrillation (AF) may be treated less actively with oral
anticoagulation (OAC) than men. Patients and methods We assessed sex differences in the …

Background. Prevention of stroke and systemic embolism (SE) prevention in patients with
atrial fibrillation (AF) has radically changed in recent years. Data on contemporary utilization …

Background Anticoagulation therapy is a standard treatment for stroke prevention in patients
with non-valvular atrial fibrillation (NVAF) that have risk factors for stroke. However …

Objective To assess whether women with atrial fibrillation (AF) have a higher risk of adverse
events than men during long-term follow-up since controversial data have been published …